Produktinformation
IMB-808 is a synthetic, small molecule that was designed to target the low-density lipoprotein-cholesterol (LDL-C) receptor. The drug inhibits the binding of cholesterol to the LDL receptor, which prevents it from entering cells and being converted into bile acids. IMB-808 has been shown to decrease hepatic steatosis, cellular uptake, and acid ph in wild-type mice. This drug also decreases the synthesis of fatty acids and oxysterols, which are products of lipid metabolism. IMB-808 has been shown to inhibit the ATP binding cassette transporter A1 (ABCA1) and fatty acid receptor α (FARα).
IMB-808 has also been shown to be active against caco-2 cells, an intestinal cell line that is often used for studies on cholesterol absorption. In this assay, IMB-808 inhibited cholesterol uptake by these cells with an IC50 of 0.8 μM.
Chemische Eigenschaften
Technische Anfrage zu: 3D-VJB76870 IMB-808
Wenn Sie ein Angebot anfordern oder eine Bestellung aufgeben möchten, legen Sie stattdessen die gewünschten Produkte in Ihren Warenkorb und fordern Sie dann ein Angebot oder eine Bestellung an aus dem Warenkorb. Es ist schneller, billiger und Sie können von den verfügbaren Rabatten und anderen Vorteilen profitieren.
